Pathophysiologic investigations demonstrated that EBF1 knockdown increases cell viability, wound healing, and cell migration, as well as the expression of CD133, Oct3/4 and TFF1 in CCA (25). The gene discussed is EBF1; the disease is cholangiocarcinoma.